Lv4
612 积分 2024-07-21 加入
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
1个月前
已完结
Validation of the Dutch Translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): A Health-Related Quality of Life Questionnaire in Inflammatory Bowel Disease
1个月前
已完结
Allostatic Load and Mortality: A Systematic Review and Meta-Analysis
1个月前
已完结
Health risk behaviours and allostatic load: A systematic review
1个月前
已完结
Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050
1个月前
已完结
Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990-2021 to 2045
1个月前
已完结
Global burden of metabolic diseases, 1990–2021
1个月前
已完结
Current status and future trends of the global burden of MASLD
1个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
1个月前
已完结
Association of Food Insecurity with the Prevalence and Liver-related Mortality of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
1个月前
已完结
皖公网安备34019202002308
